Inogen (INGN)

• Market cap: $168M
• 1 day: -2.95%
• 5 days: -5.59%
• 1 month: 1.79%
• 3 months: -16.11%
• 6 months: -30.25%
• Year to date: -31.99%
• 1 year: -20.58%
• 5 years: -81.83%
• 10 years: -85.13%
• Sector: Healthcare
• Industry: Medical Devices

About: Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Employees: 766

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1,500% more call options, than puts

Call options by funds: $144K | Put options by funds: $9K

53% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 34

6% less funds holding

Funds holding: 135 [Q4 2024] → 127 (-8) [Q1 2025]

13.51% less ownership

Funds ownership: 84.33% [Q4 2024] → 70.82% (-13.51%) [Q1 2025]

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

27% less capital invested

Capital invested by funds: $184M [Q4 2024] → $134M (-$50.3M) [Q1 2025]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $7 12% upside
• Avg. target: $9.50 52% upside
• High target: $12 92% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Needham Mike Matson	92% upside $12	Buy Upgraded	22 May 2025
Stifel Mathew Blackman	12% upside $7	Hold Maintained	8 May 2025